EE65 Evaluating the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Strategy in Oncology and Implications for Policy: A Literature Review
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.337
https://www.valueinhealthjournal.com/article/S1098-3015(23)03467-8/fulltext
Title :
EE65 Evaluating the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Strategy in Oncology and Implications for Policy: A Literature Review
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03467-8&doi=10.1016/j.jval.2023.09.337
First page :
Section Title :
Open access? :
No
Section Order :
12362